Status:
UNKNOWN
Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention
Lead Sponsor:
Jacobs Neurological Institute
Collaborating Sponsors:
University at Buffalo Neurosurgery
Genentech, Inc.
Conditions:
Stroke
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
The purpose of the trial is to study the safety and the effectiveness of using CT Perfusion studies as an indicator to treat stroke patients with unknown time of onset.
Eligibility Criteria
Inclusion
- To be eligible for entry into this study, candidates must meet all of the following eligibility criteria at the time of Emergency Department presentation:
- Age: 18-80 years old
- Ischemic Wake Up Stroke (Unknown time of onset but less than 24 hours since last seen normal)
- National Institute of Health Stroke Scale (NIHSS) 8-22
- Evidence of penumbra on Computed Tomography Perfusion(CTP) as mentioned above
- Alberta Stroke Program Early Computed Tomography (CT) Score (ASPECTS 7 or more)
- Signed informed consent
Exclusion
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2014
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01455935
Start Date
November 1 2011
End Date
February 1 2014
Last Update
March 30 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Millard Fillmore Gates Circle Hospital
Buffalo, New York, United States, 14209